Comparison of comorbidities between two different subgroups in combined assessment of COPD Source: International Congress 2016 – Postural balance, respiratory muscles, and comorbidities in chronic respiratory disease Year: 2016
Cardiac events among patients with CV comorbidities: Pooled analysis of COPD trials comparing tiotropium with salmeterol Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD Year: 2013
Comparison of different activity measures in patients with severe COPD Source: Eur Respir J 2006; 28: Suppl. 50, 68s Year: 2006
Efficiency of different multidimensional indexes for the assessment of the risk of exacerbations in patients with COPD Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020
Comparison of functionality and symptoms in COPD patients with different nutritional status Source: International Congress 2016 – Treatment and assessment of functional outcomes in cardiorespiratory physiotherapy Year: 2016
Relationship between change in trough FEV1 and COPD patient outcomes: Pooled analysis of 23 clinical trials in patients with COPD Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015
Comparison between COPD and non-COPD patients with established cardiovascular diseases: A profiling of respiratory symptoms and functional status Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010
Efficiency of different approaches for the assessment of the risk of exacerbations in patients with COPD Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019
Comparison of cardiovascular safety in a pooled analysis of COPD trials comparing tiotropium with salmeterol Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD Year: 2013
Evaluation of the individual bronchodilator response in patients with severe COPD Source: Eur Respir J 2002; 20: Suppl. 38, 246s Year: 2002
Using different pulmonary function parameters for establising reversibility in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 808s Year: 2006
Do different combinations of bronchodilator therapies have different effects on health status in patients with COPD? Source: Eur Respir J 2003; 22: Suppl. 45, 52s Year: 2003
Comparisons among various QOL assessments and clinical outcomes for one year in elderly patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2004; 24: Suppl. 48, 66s Year: 2004
Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD Year: 2013
Effects of pulmonary rehabilitation on different outcomes and at different times in subjects suffering from stable COPD Source: Annual Congress 2006 - Outcomes in pulmonary rehabilitation Year: 2006
Baseline characteristics of COPD patients with frequent COPD exacerbations in tiotropium trials Source: Eur Respir J 2006; 28: Suppl. 50, 175s Year: 2006
Clinical and inhaled drug profile of COPD patients with indication for beta-blockers who are on beta-blockers Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013
Correlation between indices of quality of life and spirography in patients with asthma in combination with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 46s Year: 2002
Comparative effectiveness of two different doses of inhaled corticosteroid in triple therapy on exacerbations in patients with severe COPD: a real-world study Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19 Year: 2021
Comparison of clinical characteristics between stable COPD patients with- and without mild bronchiectasis Source: Eur Respir J 2002; 20: Suppl. 38, 257s Year: 2002